Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The United States does not have a coherent framework for managing the costs and distribution of breakthrough medications that address common chronic conditions
Abstract Background: Psoriasis (PsO) and psoriatic arthritis (PsA) are chronic immune-mediated diseases often associated with obesity, metabolic syndrome, and type 2 diabetes mellitus
The SURMOUNT-4 trial assessed the weight maintenance with tirzepatide and had also two periods: a 36-week open-label lead-in period during which all participants took tirzepatide, followed by a 52-week double-blind treatment period during which participants were randomised to either continue on tirzepatide or switch to placebo
Tirzepatide dosing follows a similar escalation pattern from 2.5mg through 5mg, 7.5mg, 10mg, 12.5mg, and 15mg
In addition to semaglutide, Direct Meds USA offers tirzepatide-based compounded programs for patients seeking dual GIP/GLP-1 receptor agonism
further notes that a Change.org petition started by the petitioners on this issue has garnered over 94,000 signatures
